Market Overview
The Asia Pacific CGM devices market encompasses sensor-based systems, transmitters, and receivers designed for continuous tracking of blood glucose levels in diabetic patients. India represents a critical growth market within this region, supported by one of the world's largest diabetic populations and rapidly expanding healthcare infrastructure. The market valuation reflects the significant shift from traditional finger-prick testing to automated monitoring solutions that provide real-time data and improved patient outcomes.
- •Market valued at $11.23 billion in 2025 with projected expansion through 2035
- •Covers sensor systems, transmitters, receivers, and digital connectivity components
- •India accounts for a substantial share of Asia Pacific market volume due to high diabetes prevalence
Growth Drivers
The primary driver of market expansion is the escalating prevalence of diabetes across India and the broader Asia Pacific region, where urbanization and lifestyle changes have significantly increased disease burden. Growing awareness about proactive diabetes management and the clinical benefits of continuous monitoring over periodic finger-prick testing has accelerated adoption rates among patients and healthcare providers. Additionally, improving healthcare accessibility, rising healthcare spending, and government initiatives to enhance diabetes care have created favorable conditions for sustained market growth.
- •Rising diabetes incidence driven by urbanization, sedentary lifestyles, and dietary changes
- •Increasing patient and physician preference for real-time monitoring over traditional testing methods
- •Government healthcare initiatives and expanding insurance coverage for diabetes management devices
Segmentation and Regional Analysis
The market is segmented by product type into sensors, transmitters, and receivers, with sensors representing the largest revenue segment due to their recurring replacement requirements. Based on connectivity, devices are categorized as Bluetooth-enabled systems, cellular-connected devices, and standalone monitors, with connected solutions gaining prominence. India's vast patient population, expanding middle class, and improving healthcare infrastructure position it as a key growth driver within Asia Pacific, alongside markets in China, Southeast Asia, Japan, and Australia.
- •Sensors represent the dominant product segment requiring periodic replacement
- •Connected devices with smartphone integration represent the fastest-growing category
- •India, China, and Southeast Asia collectively drive regional market expansion
Trends and Outlook
What are the recent trends and outlook?
The market is trending toward more compact, user-friendly devices with extended sensor wear durations and seamless smartphone integration. Integration with digital health platforms and cloud-based analytics is becoming standard, enabling remote patient monitoring and personalized diabetes management recommendations. Looking forward, the market is expected to maintain robust growth momentum through 2035, driven by ongoing technological innovation, gradual price reductions, and expanding healthcare access across emerging Asia Pacific economies including India.
- •Miniaturization and extended-wear sensors improving patient convenience and treatment adherence
- •Digital health integration enabling remote monitoring and data-driven clinical decision-making
- •Projected continued expansion as device affordability improves across emerging markets
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.